Nudge in EHR Can Reduce Unnecessary Sentinel Lymph Node Biopsy
By Elana Gotkine HealthDay Reporter
THURSDAY, July 25, 2024 -- A nudge intervention in the electronic health record (EHR) targeting surgeons can reduce sentinel lymph node biopsy (SLNB) among women who meet the Choosing Wisely criteria for SLNB omission, according to a study published online July 17 in JAMA Surgery.
Neil Carleton, Ph.D., from UPMC Hillman Cancer Center in Pittsburgh, and colleagues examined whether an EHR-based nudge intervention targeting surgeons in their first outpatient visit with patients can reduce the rates of SLNB. Data were obtained for female patients meeting the Choosing Wisely criteria for omission of SLNB (aged ≥70 years with cT1 and cT2, cN0, HR+/HER2− breast cancer); a column nudge was embedded into the surgeon's schedule in the EHR for these patients. The study compared a 12-month preintervention control period with a 12-month intervention period.
The researchers found that unadjusted rates of SLNB decreased by 23.1 percentage points in the intervention period compared with the control period (decrease from 46.9 percent pre-nudge to 23.8 percent after). Following nudge deployment, there was a reduction in the rate of SLNB (adjusted odds ratio, 0.26). The intervention was scored highly by surgeons on acceptability, appropriateness, and feasibility. The intervention helped remind surgeons of potential Choosing Wisely applicability, without the need for additional clicks or actions at the patient visit, which facilitated use.
"Based on these findings, an EHR nudge is an evidence-based solution to deimplement SLNB and may be extended to other practice settings," the authors write.
One author has a patent for application-specific processing of a disease-specific semantic model instance pending with Caldex.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2024
Read this next
Gender-Based Variation Seen in Medicare Reimbursement for Surgery
THURSDAY, July 25, 2024 -- Considerable gender-based variation is seen in practice patterns and reimbursement among different surgical subspecialties serving the Medicare...
Preop Lab Values May ID Risk of Postarthroplasty Joint Infection in Morbid Obesity
THURSDAY, July 25, 2024 -- Certain preoperative laboratory values may predict risk of periprosthetic joint infection (PJI) among individuals with morbid obesity undergoing...
Survey: Few Women With Uterine Fibroids Offered Less Invasive Treatment Options
WEDNESDAY, July 24, 2024 -- Most U.S. women with uterine fibroids report being offered hysterectomies over minimally invasive treatments, according to survey results released by...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.